Deals this week: Philips, HeartHero, SirenMD

9 November 2018 (Last Updated November 8th, 2018 16:01)

Royal Philips has partnered with Allm to develop novel mobile diagnostic, acute and homecare products. 

Royal Philips has partnered with Allm to develop novel mobile diagnostic, acute and homecare products.

Philips has acquired a minority interest in Allm as part of the deal.

Allm’s mobile communications solutions will be integrated with Philips’ emergency care and resuscitation solutions.

The partnership will enhance the digitisation of Philips’ emergency care product portfolio with Allm’s next-generation technologies and medical communications platforms. It will enable the two companies to improve the health management of patients.

Based in the Netherlands, Royal Philips is a technology company specialising in the areas of healthcare and lighting, while Allm is a medical communications platform company in Japan.

HeartHero has entered an agreement to license VivaQuant MDSP’s cardiac arrhythmia detection technology.

HeartHero will employ the technology for the advancement of its portable Automated External Defibrillator (AED), which is used for the detection of life-threatening heart disorders.

"The integration of technologies will also reduce the gap between the patient and emergency medical services to improve the chances of survival in the patients."

VivaQuantMDSP’s technology will help improve the processing and analysis of ECG data by its state-of-the-art embedded algorithms of its ECG software.

The integration of technologies will also reduce the gap between the patient and emergency medical services (EMS) to improve the chances of survival in the patients.

HeartHero is a medical device start-up, while VivaQuant MDSP is a medical device company. Both companies are based in the US.

DJO has signed a deal to become the exclusive sales representative for the SirenMD’s sports team market.

SirenMD software compiles injury data of athletes and provides a comprehensive report to the conference and member institutions. It offers a more integrated, compliant and efficient sharing of patients’ data.

DJO will provide a new and innovative care platform to existing customers and sales channels. It will enable SirenMD to provide improved care for athletes and sports teams.

DJO is a medical device company, while SirenMD is a technology platform company focussing on athlete health. The parties are based in the US.